PFM
Privium Fund Management Portfolio holdings
AUM
$543M
1-Year Est. Return
99.51%
This Fund
S&P 500
1 Year Est. Return
+99.51%
AUM
$543M
AUM Growth
-$13.1M
(-2.4%)
Holding
65
Top Buys
| 1 | +$7.74M | |
| 2 | +$6.94M | |
| 3 | +$4.76M | |
| 4 |
Biogen
BIIB
|
+$3.52M |
| 5 |
enGene Therapeutics Inc. Common Stock
ENGN
|
+$2.82M |
Top Sells
| 1 | +$16.9M | |
| 2 | +$6.87M | |
| 3 | +$6.41M | |
| 4 |
Arrowhead Research
ARWR
|
+$3.71M |
| 5 |
Sea Limited
SE
|
+$3.26M |
Sector Composition
| 1 | Healthcare | 29.46% |
| 2 | Consumer Discretionary | 27.3% |
| 3 | Technology | 25.78% |
| 4 | Financials | 8.49% |
| 5 | Communication Services | 7.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Voyager Therapeutics
VYGR
$223M
| $373K | 0.07% |
95,000
+50,000
|
|
||
52
Fate Therapeutics
FATE
$144M
| $363K | 0.07% |
369,100
+35,881
|
|
||
53
Valaris
VAL
$6.76B
| $318K | 0.06% |
6,315
-2,000
|
|
||
54
Noble Corp
NE
$7.8B
| $306K | 0.06% |
10,849
-3,438
|
|
||
55
Sprott Uranium Miners ETF
URNM
$2.32B
| $297K | 0.05% |
5,407
-6,041
|
|
||
56
Tidewater
TDW
$4.27B
| $277K | 0.05% |
5,483
|
|
||
57
Nomad Foods
NOMD
$1.4B
| $103K | 0.02% |
+8,199
|
|
||
|
ABVX
58
Abivax
ABVX
$9.97B
| – | – |
-30,412
|
|
||
59
Acadia Pharmaceuticals
ACAD
$3.71B
| – | – |
-70,400
|
|
||
60
ALX Oncology
ALXO
$224M
| – | – |
-509,059
|
|
||
61
Pan American Silver
PAAS
$24.5B
| – | – |
-18,531
|
|
||
|
RNAM
62
DELISTED
Avidity Biosciences
RNAM
| – | – |
-53,000
|
|
||
63
Roivant Sciences
ROIV
$20.2B
| – | – |
-126,923
|
|
||
64
Recursion Pharmaceuticals
RXRX
$1.87B
| – | – |
-119,000
|
|
||
65
Sibanye-Stillwater
SBSW
$9.49B
| – | – |
-26,232
|
|